We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$47B
AUM Growth
+$1.15B
Cap. Flow
-$971M
Cap. Flow %
-2.07%
Top 10 Hldgs %
6.79%
Holding
1,899
New
95
Increased
1,009
Reduced
562
Closed
78

Sector Composition

Rank Sector Weight
1 Financials 17.95%
2 Industrials 14.14%
3 Technology 13.58%
4 Consumer Discretionary 11.68%
5 Healthcare 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVTR
1726
DELISTED
Nuvectra Corporation Common Stock
NVTR
$42K ﹤0.01%
+2,027
New +$34.2K
GNMK
1727
DELISTED
GenMark Diagnostics, Inc
GNMK
$41K ﹤0.01%
6,439
DEI icon
1728
Douglas Emmett
DEI
$1.98B
$40K ﹤0.01%
1,005
CYS
1729
DELISTED
CYS Investments Inc.
CYS
$40K ﹤0.01%
5,310
HR
1730
DELISTED
Healthcare Realty Trust Incorporated
HR
$39K ﹤0.01%
1,340
NLY icon
1731
Annaly Capital Management
NLY
$17.1B
$38K ﹤0.01%
929
-1,550
-63% -$64.6K
CORI
1732
DELISTED
Corium International, Inc.
CORI
$38K ﹤0.01%
4,686
ARWR icon
1733
Arrowhead Research
ARWR
$12.3B
$35K ﹤0.01%
2,599
-1,000
-28% -$9.35K
RETA
1734
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$35K ﹤0.01%
1,000
RARE icon
1735
Ultragenyx Pharmaceutical
RARE
$2.51B
$34K ﹤0.01%
443
CBLK
1736
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$31K ﹤0.01%
+1,195
New +$30.8K
COLL icon
1737
Collegium Pharmaceutical
COLL
$1.16B
$29K ﹤0.01%
+1,227
New +$30.2K
NWS icon
1738
News Corp Class B
NWS
$17.3B
$29K ﹤0.01%
1,842
-38
-2% -$611
DCPH
1739
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$29K ﹤0.01%
+732
New +$21.5K
OMER icon
1740
Omeros
OMER
$908M
$28K ﹤0.01%
1,570
TUSK icon
1741
Mammoth Energy Services
TUSK
$132M
$28K ﹤0.01%
816
-30,401
-97% -$1.07M
DOMO icon
1742
Domo
DOMO
$183M
$27K ﹤0.01%
+1,000
New +$27.3K
JBGS
1743
JBG SMITH
JBGS
$659M
$27K ﹤0.01%
744
TTSH
1744
DELISTED
Tile Shop Holdings
TTSH
$25K ﹤0.01%
3,187
DVAX
1745
DELISTED
Dynavax Technologies
DVAX
$24K ﹤0.01%
1,557
TGTX icon
1746
TG Therapeutics
TGTX
$7.14B
$24K ﹤0.01%
1,841
ZLAB icon
1747
Zai Lab
ZLAB
$2.08B
$24K ﹤0.01%
+1,018
New +$22K
SGYP
1748
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$24K ﹤0.01%
13,507
CONE
1749
DELISTED
CyrusOne Inc Common Stock
CONE
$22K ﹤0.01%
375
ADMS
1750
DELISTED
Adamas Pharmaceuticals
ADMS
$22K ﹤0.01%
845

Similar funds

Victory Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Victory Capital Management held 1,899 positions worth $47B, up 2.5% from $45.8B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Victory Capital Management's Q2 2018 filing shows 95 new, 1,009 increased, 562 reduced and 78 closed positions. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 56,038 shares worth $70.6M. The largest sale was Keysight, an estimated $104M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.

  • Victory Capital Management's largest Q2 2018 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 56,038 shares worth $70.6M.
  • Victory Capital Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q2 2018, an estimated $110M increase.
  • Victory Capital Management's biggest Q2 2018 reduction was Keysight, cutting an estimated $104M.
  • Victory Capital Management fully exited Liberty Broadband Class C in Q2 2018, selling an estimated $50.7M.
  • Victory Capital Management's ten largest holdings make up 6.8% of its $47B portfolio in Q2 2018.
  • Victory Capital Management opened 95 new positions and closed 78 in Q2 2018.
  • Victory Capital Management's portfolio value rose 2.5% quarter-over-quarter to $47B.

Based on Victory Capital Management's 13F filing for Q2 2018, filed 2 Aug 2018.